Some aches and pains are normal as we age, but this particular leg pain should not be ignored.

Rochester, NY - Researchers are calling for beta-blocker treatment for patients with intermittent claudication, arguing that it is "old school" to avoid them in this high-risk group [1]. The new study ...

Although pentoxifylline and cilostazol may provide symptomatic relief, the management of IC must address the underlying problem of PVD. Resolution of risk factors, such as smoking, diabetes, ...

Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, today announced it has completed the planned enrollment of 150 patients in a global Phase II trial of its ...

Though many people think of injuries or accidents when they think of amputations, more than half result from complications of cardiovascular issues, leading amputations caused by the effects of ...

Drug-coated stents and balloons were not associated with reduced risk of amputation or improved quality of life compared with uncoated devices in two trials in peripheral artery disease (PAD), ...

MADRID -- Paclitaxel coating added no benefit to balloons and stents for endovascular peripheral arterial disease (PAD) intervention in the SWEDEPAD 1 and 2 trials -- and in fact, researchers said ...

Please provide your email address to receive an email when new articles are posted on . Drug-coated devices did not improve amputation rates vs. uncoated devices in patients with limb-threatening ...

* Pluristem's IC trial is evaluating safety and efficacy of PLX-PAD cells as compared to placebo Source text for Eikon: Further company coverage: ...